Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
| multiple interactions | ISO | RGD:2319763 | 6480464 | CTD | [13,17,21-trimethyldocosa-12,16,20-trien-11-one binds to and results in decreased activity of RPE65 protein] which results in decreased abundance of Retinaldehyde
[3,7,11-trimethyldodeca-2,6,10-trienoic acid hexadecylamide binds to and results in decreased activity of RPE65 protein] which results in decreased abundance of Retinaldehyde
[Isotretinoin binds to and results in decreased activity of RPE65 protein] which results in decreased abundance of Retinaldehyde
| PMID:16411761
|
| increases chemical synthesis | EXP | | 6480464 | CTD | RPE65 protein results in increased chemical synthesis of Retinaldehyde
| PMID:16828753
|
| multiple interactions | ISO | RGD:732417 | 6480464 | CTD | [13,17,21-trimethyldocosa-12,16,20-trien-11-one binds to and results in decreased activity of RPE65 protein] which results in decreased abundance of Retinaldehyde
[3,7,11-trimethyldodeca-2,6,10-trienoic acid hexadecylamide binds to and results in decreased activity of RPE65 protein] which results in decreased abundance of Retinaldehyde
[Isotretinoin binds to and results in decreased activity of RPE65 protein] which results in decreased abundance of Retinaldehyde
| PMID:16411761
|
| multiple interactions | ISO | RGD:732417 | 6480464 | CTD | Retinaldehyde inhibits the reaction [RPE65 exon mutant form results in decreased uptake of Manganese]
| PMID:19060264
|
| increases chemical synthesis | ISO | RGD:732417 | 6480464 | CTD | RPE65 protein results in increased chemical synthesis of Retinaldehyde
| PMID:16026160
|
| multiple interactions | ISO | RGD:621396 | 6480464 | CTD | [3,7,11-trimethyldodeca-2,6,10-trienoic acid hexadecylamide binds to and results in decreased activity of RPE65 protein] which results in decreased abundance of Retinaldehyde
[Isotretinoin binds to and results in decreased activity of RPE65 protein] which results in decreased abundance of Retinaldehyde
[13,17,21-trimethyldocosa-12,16,20-trien-11-one binds to and results in decreased activity of RPE65 protein] which results in decreased abundance of Retinaldehyde
| PMID:16411761
|
| increases metabolic processing | ISO | RGD:732417 | 6480464 | CTD | RPE65 protein results in increased metabolism of Retinaldehyde
| PMID:17251447
|
| multiple interactions | ISO | | 6480464 | CTD | [3,7,11-trimethyldodeca-2,6,10-trienoic acid hexadecylamide binds to and results in decreased activity of RPE65 protein] which results in decreased abundance of Retinaldehyde
[13,17,21-trimethyldocosa-12,16,20-trien-11-one binds to and results in decreased activity of RPE65 protein] which results in decreased abundance of Retinaldehyde
[Isotretinoin binds to and results in decreased activity of RPE65 protein] which results in decreased abundance of Retinaldehyde
| PMID:16411761
|
| increases metabolic processing | ISO | | 6480464 | CTD | RPE65 protein results in increased metabolism of Retinaldehyde
| PMID:17251447
|
| increases chemical synthesis | ISO | | 6480464 | CTD | RPE65 protein results in increased chemical synthesis of Retinaldehyde
| PMID:16026160
|
| multiple interactions | ISO | | 6480464 | CTD | Retinaldehyde inhibits the reaction [RPE65 exon mutant form results in decreased uptake of Manganese]
| PMID:19060264
|